Oramed Pharmaceuticals ORMP Q2 2026 earnings

FAQ

When did Oramed Pharmaceuticals report Q2 2026 earnings?

Oramed Pharmaceuticals (ORMP) reported Q2 2026 earnings on August 10, 2026 before market open.

What were Oramed Pharmaceuticals's Q2 2026 revenue and EPS?

Oramed Pharmaceuticals reported eps of $-0.09 for Q2 2026.

Did Oramed Pharmaceuticals beat estimates in Q2 2026?

EPS missed the consensus estimate of $0.43 by $0.52.

How did Oramed Pharmaceuticals's Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 80.0% from $-0.05.

Where can I find Oramed Pharmaceuticals's Q2 2026 SEC filings?

You can read the 10-Q periodic report (0001213900-26-087361) directly on SEC EDGAR. The filing index links above go to sec.gov.